BiomX Inc. (NYSEAMERICAN:PHGE) Sees Large Decrease in Short Interest

BiomX Inc. (NYSEAMERICAN:PHGE) was the target of a significant decrease in short interest during the month of November. As of November 30th, there was short interest totalling 55,500 shares, a decrease of 18.4% from the November 15th total of 68,000 shares. Currently, 0.5% of the shares of the stock are short sold. Based on an average daily volume of 86,400 shares, the days-to-cover ratio is currently 0.6 days.

BiomX Stock Performance

NYSEAMERICAN:PHGE traded up $0.03 during trading hours on Monday, reaching $0.67. 71,068 shares of the company traded hands, compared to its average volume of 108,666. The stock has a market cap of $12.09 million, a PE ratio of -0.20 and a beta of 1.31. BiomX has a 1-year low of $0.48 and a 1-year high of $8.55.

BiomX Company Profile

BiomX Inc, a clinical-stage microbiome company, develops products using natural and engineered phage technologies designed to target and kill specific harmful bacteria. It targets bacteria that affect the appearance of skin, as well as chronic diseases, such as inflammatory bowel diseases (IBD), primary sclerosing cholangitis (PSC), cystic fibrosis (CF), atopic dermatitis, and colorectal cancer (CRC).